Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2018

01-08-2018 | Original Article

Retrospective surveillance of antibiotic use in maternity wards and neonatal intensive care units in Saint Petersburg, Russia

Authors: Timofey L. Galankin, Alexey S. Kolbin, Sergey V. Sidorenko, Alexey A. Kurylev, Elena A. Malikova, Yuri V. Lobzin, Dmitry O. Ivanov, Nikolay P. Shabalov, Anton V. Mikhailov, Nikolay N. Klimko, Gennadiy V. Dolgov

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2018

Login to get access

Abstract

Antibiotic overuse in infants is associated with an increased risk of serious adverse events. Development of antibiotic stewardship programs aimed at reducing overall antibiotic consumption requires epidemiological surveillance. Retrospective surveillance and evaluation of all antibiotics provided to every infant admitted to maternal wards or neonatal intensive care units (NICUs) from 01 January 2014 to 31 December 2014 were performed in five medical centers of Saint Petersburg, Russia. Types of antibiotics and dates of administration were recorded. Antibiotic use was quantified by length of therapy (length of therapy, LOT, per 1000 patient-days, PD) and days of therapy (DOT/1000 PD). An additional parameter named “instant DOT/1000 PD” was introduced by authors for assessment of longitudinal patterns of administrations. Antibiotic load was 825.6 DOT/1000 PD in maternity wards and 1425.8 DOT/1000 PD in the NICUs. These levels are two to four times higher than DOTs reported in the USA for a level III NICU (348 DOT/1000PD). Antibiotic load was associated with the length of hospital stay (LOS) and birth weight. These associations were distorted when assessed using the conventional parameters, LOT and DOT, because they do not reflect the longitudinal component of treatment and underestimate antibiotic load when a patient stays in hospital without treatment. The proposed additional parameter successfully overcame these flaws and uncovered hidden associations. Severe overuse of antibiotics may be taking place in Russia and antibiotic stewardship development should be urged. Instant DOT/1000 PD is a more powerful tool in assessing treatment patterns than DOT/1000 PD.
Literature
1.
go back to reference WHO, 2014. Antimicrobial resistance: global report on surveillance. 232 pp. WHO, 2014. Antimicrobial resistance: global report on surveillance. 232 pp.
2.
go back to reference CDC, 2013. Antibiotic resistance threats in the United States, 2013. 113 pp. CDC, 2013. Antibiotic resistance threats in the United States, 2013. 113 pp.
5.
go back to reference Clark RH, Bloom BT, Spitzer AR et al (2006) Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 117:1979–1987CrossRefPubMed Clark RH, Bloom BT, Spitzer AR et al (2006) Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 117:1979–1987CrossRefPubMed
6.
go back to reference Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL et al (2005) Pediatric Prevention Network. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J 24:766–773CrossRefPubMed Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL et al (2005) Pediatric Prevention Network. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J 24:766–773CrossRefPubMed
7.
go back to reference Tsai MH, Chu SM, Hsu JF et al (2014) Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU. Pediatrics 133:e322–e329CrossRefPubMed Tsai MH, Chu SM, Hsu JF et al (2014) Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU. Pediatrics 133:e322–e329CrossRefPubMed
8.
go back to reference de Man P, Verhoeven BA, Verbrugh HA et al (2000) An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355:973–978CrossRefPubMed de Man P, Verhoeven BA, Verbrugh HA et al (2000) An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355:973–978CrossRefPubMed
9.
go back to reference Cotten CM, McDonald S, Stoll B et al (2006) National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 118:717–722CrossRefPubMed Cotten CM, McDonald S, Stoll B et al (2006) National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 118:717–722CrossRefPubMed
10.
go back to reference Cotten CM, Taylor S, Stoll B et al (2009) NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123:58–66CrossRefPubMedPubMedCentral Cotten CM, Taylor S, Stoll B et al (2009) NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123:58–66CrossRefPubMedPubMedCentral
11.
go back to reference Kuppala VS, Meinzen-Derr J, Morrow AL et al (2011) Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 159:720–725CrossRefPubMedPubMedCentral Kuppala VS, Meinzen-Derr J, Morrow AL et al (2011) Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 159:720–725CrossRefPubMedPubMedCentral
12.
go back to reference Saiman L, Ludington E, Dawson JD et al (2001) National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 20:1119–1124CrossRefPubMed Saiman L, Ludington E, Dawson JD et al (2001) National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 20:1119–1124CrossRefPubMed
13.
go back to reference Alexander VN, Northrup V, Bizzarro MJ (2011) Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 159:392–397CrossRefPubMedPubMedCentral Alexander VN, Northrup V, Bizzarro MJ (2011) Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 159:392–397CrossRefPubMedPubMedCentral
14.
go back to reference Lee JH, Hornik CP, Benjamin DK Jr et al (2013) Risk factors for invasive candidiasis in infants >1500 g birth weight. Pediatr Infect Dis J 32:222–226CrossRefPubMedPubMedCentral Lee JH, Hornik CP, Benjamin DK Jr et al (2013) Risk factors for invasive candidiasis in infants >1500 g birth weight. Pediatr Infect Dis J 32:222–226CrossRefPubMedPubMedCentral
17.
go back to reference Araujo da Silva AR, Albernaz de Almeida Dias DC, Marques AF, Biscaia di Biase C, Murni IK, Dramowski A, Sharland M, Huebner J, Zingg W. Role of antimicrobial stewardship programmes in children: a systematic review. J Hosp Infect. 2017 Aug 12. pii: S0195-6701(17)30447-4. doi: 10.1016/j.jhin.2017.08.003. Araujo da Silva AR, Albernaz de Almeida Dias DC, Marques AF, Biscaia di Biase C, Murni IK, Dramowski A, Sharland M, Huebner J, Zingg W. Role of antimicrobial stewardship programmes in children: a systematic review. J Hosp Infect. 2017 Aug 12. pii: S0195-6701(17)30447-4. doi: 10.1016/j.jhin.2017.08.003.
18.
go back to reference Barlam TF, Cosgrove SE, Abbo LM et al (2016) Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62(10):e51–e77. https://doi.org/10.1093/cid/ciw118 CrossRefPubMedPubMedCentral Barlam TF, Cosgrove SE, Abbo LM et al (2016) Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62(10):e51–e77. https://​doi.​org/​10.​1093/​cid/​ciw118 CrossRefPubMedPubMedCentral
19.
go back to reference Шабалов Н.П. Неонатология. Учебное пособие. В 2-х томах. 5-е изд., испр. и доп. — М.: МЕДпресс-информ; 2009. [Shabalov NP. Neonatologiya. Uchebnoe posobie. In 2 Volumes. 5th ed., enlarged. Moscow: MEDpress-inform; 2009. (In Russ)] Шабалов Н.П. Неонатология. Учебное пособие. В 2-х томах. 5-е изд., испр. и доп. — М.: МЕДпресс-информ; 2009. [Shabalov NP. Neonatologiya. Uchebnoe posobie. In 2 Volumes. 5th ed., enlarged. Moscow: MEDpress-inform; 2009. (In Russ)]
20.
go back to reference Руководство по перинатологии / Под ред. Иванова Д.О. — СПб.: Информ-Навигатор; 2015. — 1216 с. [Rukovodstvo po perinatologii. Ed by Ivanov DO. St. Petersburg: Inform-Navigator; 2015. 1216 p. (In Russ)] Руководство по перинатологии / Под ред. Иванова Д.О. — СПб.: Информ-Навигатор; 2015. — 1216 с. [Rukovodstvo po perinatologii. Ed by Ivanov DO. St. Petersburg: Inform-Navigator; 2015. 1216 p. (In Russ)]
22.
go back to reference Ibrahim OM, Polk RE (2014) Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am 28:195–214CrossRefPubMed Ibrahim OM, Polk RE (2014) Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am 28:195–214CrossRefPubMed
23.
go back to reference Gravatt LA, Pakyz AL (2013) Challenges in measuring antibiotic consumption. Curr Infect Dis Rep 15:559–563CrossRefPubMed Gravatt LA, Pakyz AL (2013) Challenges in measuring antibiotic consumption. Curr Infect Dis Rep 15:559–563CrossRefPubMed
24.
go back to reference Berrington A (2010) Antimicrobial prescribing in hospitals: be careful what you measure. J Antimicrob Chemother 65:163–168CrossRefPubMed Berrington A (2010) Antimicrobial prescribing in hospitals: be careful what you measure. J Antimicrob Chemother 65:163–168CrossRefPubMed
25.
go back to reference Mandy B, Koutny E, Cornette C et al (2004) Methodological validation of monitoring indicators of antibiotics use in hospitals. Pharm World Sci 26:90–95CrossRefPubMed Mandy B, Koutny E, Cornette C et al (2004) Methodological validation of monitoring indicators of antibiotics use in hospitals. Pharm World Sci 26:90–95CrossRefPubMed
29.
go back to reference Patel Brijal S, KubavatAmita R, Sondarva Divyesh B, Piparva Kiran G (2015) Drug utilization study in neonatal intensive care unit at tertiary care hospital, Rajkot, Gujarat: a prospective study. World J Pharmacy Pharmaceutical Sci 4(7):2034–2042 Patel Brijal S, KubavatAmita R, Sondarva Divyesh B, Piparva Kiran G (2015) Drug utilization study in neonatal intensive care unit at tertiary care hospital, Rajkot, Gujarat: a prospective study. World J Pharmacy Pharmaceutical Sci 4(7):2034–2042
32.
go back to reference Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. American academy of pediatrics; 2015. 1151 p. Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. American academy of pediatrics; 2015. 1151 p.
33.
go back to reference Bradley JS, Nelson JD. Nelsons pediatric antimicrobial therapy. 22nd ed. American Academy of Pediatrics; 2016. 278 p. Bradley JS, Nelson JD. Nelsons pediatric antimicrobial therapy. 22nd ed. American Academy of Pediatrics; 2016. 278 p.
34.
go back to reference Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80(2):142−145. doi: 10.1136/fn.80.2.f142 Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80(2):142−145. doi: 10.1136/fn.80.2.f142
36.
go back to reference Колбин А.С., Шабалов Н.П., Карпов О.И. Фармакоэпидемиология противоинфекционных средств у недоношенных новорожденных // Педиатрия. Журнал им. Г.Н. Сперанского. — 2004. — Т.83. — №5 — С. 69–73. [Kolbin AS, Shabalov NP, Karpov OI. Pharmacoepidemiology of anti-infectious medicaments in premature born neonates. Pediatriia. 2004;83(5):69–73. (In Russ).] Колбин А.С., Шабалов Н.П., Карпов О.И. Фармакоэпидемиология противоинфекционных средств у недоношенных новорожденных // Педиатрия. Журнал им. Г.Н. Сперанского. — 2004. — Т.83. — №5 — С. 69–73. [Kolbin AS, Shabalov NP, Karpov OI. Pharmacoepidemiology of anti-infectious medicaments in premature born neonates. Pediatriia. 2004;83(5):69–73. (In Russ).]
Metadata
Title
Retrospective surveillance of antibiotic use in maternity wards and neonatal intensive care units in Saint Petersburg, Russia
Authors
Timofey L. Galankin
Alexey S. Kolbin
Sergey V. Sidorenko
Alexey A. Kurylev
Elena A. Malikova
Yuri V. Lobzin
Dmitry O. Ivanov
Nikolay P. Shabalov
Anton V. Mikhailov
Nikolay N. Klimko
Gennadiy V. Dolgov
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3280-0

Other articles of this Issue 8/2018

European Journal of Clinical Microbiology & Infectious Diseases 8/2018 Go to the issue